Manfred Beier

Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.

ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.

Journal: International journal of molecular sciences
Published: August 31, 2022

Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.

Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.

Journal: PloS one
Published: June 07, 2022

TFF1 in Aqueous Humor-A Potential New Biomarker for Retinoblastoma.

TFF1 in Aqueous Humor-A Potential New Biomarker for Retinoblastoma.

Journal: Cancers
Published: January 04, 2022

Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma.

Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma.

Journal: Molecular oncology
Published: November 17, 2020

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations.

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations.

Journal: Cancers
Published: November 05, 2020

Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.

Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.

Journal: Scientific reports
Published: September 13, 2018

Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.

Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.

Journal: Cancer medicine
Published: November 17, 2017

TREFOIL FACTOR FAMILY 1 EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN PATIENTS WITH RETINOBLASTOMA.

TREFOIL FACTOR FAMILY 1 EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN PATIENTS WITH RETINOBLASTOMA.

Journal: Retina (Philadelphia, Pa.)
Published: October 11, 2017

Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.

Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.

Journal: International journal of cancer
Published: October 14, 2016

Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases.

Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases.

Journal: BMC research notes
Published: September 25, 2016

Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.

Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.

Journal: PloS one
Published: October 09, 2015

Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Journal: Human molecular genetics
Published: March 13, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026